Leon Ivory
Directeur/Membre du Conseil chez Kancer Ltd.
Profil
Leon Ivory is currently the Director at Kancer Ltd.
and the Non-Executive Director at Ivory & Co. Pty Ltd.
He previously held positions as the Chairman at Eneco Refresh Ltd., Director at Provalis Plc, Independent Non-Executive Director at Botanix Pharmaceuticals Ltd., Director at Probiomics Ltd., Director at Arbuthnot Latham Bank Ltd., and Director at Foreign Commerce Bank.
Postes actifs de Leon Ivory
| Sociétés | Poste | Début |
|---|---|---|
Kancer Ltd.
 Kancer Ltd. Miscellaneous Commercial ServicesCommercial Services Kancer Ltd. engages in the provision of cancer treatments. Its projects include personalized medicine, targeted destruction of cancer cells, oral granulocyte colony stimulating factor , and oral interferon. The company was founded by Glen Travers and Roger New in 1980 and is headquartered in Saint Helier, the United Kingdom. | Directeur/Membre du Conseil | 16/03/2011 |
| Ivory & Co. Pty Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Leon Ivory
| Sociétés | Poste | Fin |
|---|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | President | 27/03/2012 |
| ENECO REFRESH LIMITED | Président | - |
| Provalis Plc | Directeur/Membre du Conseil | - |
Probiomics Ltd.
 Probiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Probiomics Ltd. is an Australian biotechnology company, which develops probiotic and biomolecular technology for commercial applications in consumer health, functional foods and pharmaceutical products. The firm's activities are the development and commercialization of products containing its probiotic strain for human health benefit, and discovery of novel biotherapeutic molecules from probiotics. It also produces a practitioner-only product, Progastrim, sold to Australian naturopaths, to help stabilise and maintain an optimal intestinal flora , and which has been shown in clinical studies to assist in the management of gastrointestinal disturbances, including diarrhoea. The company was founded in 1997 and is headquartered in Gordon, Australia. | Directeur/Membre du Conseil | - |
| Foreign Commerce Bank | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ENECO REFRESH LIMITED | Consumer Non-Durables |
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Provalis Plc | Health Technology |
Probiomics Ltd.
Probiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Probiomics Ltd. is an Australian biotechnology company, which develops probiotic and biomolecular technology for commercial applications in consumer health, functional foods and pharmaceutical products. The firm's activities are the development and commercialization of products containing its probiotic strain for human health benefit, and discovery of novel biotherapeutic molecules from probiotics. It also produces a practitioner-only product, Progastrim, sold to Australian naturopaths, to help stabilise and maintain an optimal intestinal flora , and which has been shown in clinical studies to assist in the management of gastrointestinal disturbances, including diarrhoea. The company was founded in 1997 and is headquartered in Gordon, Australia. | Commercial Services |
Kancer Ltd.
Kancer Ltd. Miscellaneous Commercial ServicesCommercial Services Kancer Ltd. engages in the provision of cancer treatments. Its projects include personalized medicine, targeted destruction of cancer cells, oral granulocyte colony stimulating factor , and oral interferon. The company was founded by Glen Travers and Roger New in 1980 and is headquartered in Saint Helier, the United Kingdom. | Commercial Services |
| Arbuthnot Latham Bank Ltd. | |
| Foreign Commerce Bank | |
| Ivory & Co. Pty Ltd. |